In vitro characterisation and expansion of human regulatory T cells for their in vivo application in the induction of tolerance in haematopoietic stem cell and solid organ transplantation

Solid organ transplantation (SOT) is considered the treatment of choice for many end-stage organ diseases. Thus far, short term results are excellent, with patient survival rates greater than 90% one year post-surgery, but there are several problems with the long term acceptance and use of immunosuppressive drugs. Hematopoietic Stem Cells Transplantation (HSCT) concerns the infusion of haematopoietic stem cells to re-establish acquired and congenital disorders of the hematopoietic system. The main side effect is the Graft versus Host Disease (GvHD) where donor T cells can cause pathology involving the damage of host tissues. Patients undergoing acute or chronic GvHD receive immunosuppressive regimen that is responsible for several side effects. The use of immunosuppressive drugs in the setting of SOT and GvHD has markedly reduced the incidence of acute rejection and the tissue damage in GvHD however, the numerous adverse side effects observed boost the development of alternative strategies to improve the long-term outcome. To this effect, the use of CD4+CD25+FOXP3+ regulatory T cells (Treg) as a cellular therapy is an attractive approach for autoimmunity disease, GvHD and limiting immune responses to allograft after transplantation. Treg have a pivotal role in maintaining peripheral immunological tolerance, by preventing autoimmunity and chronic inflammation. Results of my thesis provide the characterization and cell processing of Tregs from healthy controls and patients in waiting list for liver transplantation, followed by the development of an efficient expansion-protocol and the investigation of the impact of the main immunosuppressive drugs on viability, proliferative capacity and function of expanded cells after expansion. The conclusion is that ex vivo expansion is necessary to infuse a high Treg dose and although many other factors in vivo can contribute to the success of Treg therapy, the infusion of Tregs during the administration of the highest dose of immunosuppressants should be carefully considered.

Design of a new harrow type wool transport mechanism to reduce fibre entanglement

The wool is entangled at several stages of its processing. In the conventional scouring machines, the prongs or the rakes agitate the wool and lead the fiber entanglement. Several scouring systems have been commercialized in order to reduce the fiber entanglement. In spite of the existing technologies, the conventional scouring machines are widely used in wool processing. In this thesis, a new approach for the harrow type wool transport mechanism has been introduced. The proposed mechanism has been designed based on the motion of the conventional harrow type wool transport mechanism by exploiting new synthesis concepts. The developed structure has been synthesized based on the Hrones and Nelson's "Atlas of four bar linkages". The four bar linkage has been applied for the desired trajectory of the developed wool transport mechanism. The prongs of the developed mechanism immerse the wool into the scouring liquor and gently propel forward toward the end of the machine with approximately straight line motion in a certain length instead of circular or elliptical motion typical of the conventional machines.